{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T07:46:59Z","timestamp":1774424819820,"version":"3.50.1"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,24]]},"DOI":"10.7759\/cureus.105804","type":"journal-article","created":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T06:00:46Z","timestamp":1774418446000},"source":"Crossref","is-referenced-by-count":0,"title":["Real-World Effectiveness of Biologic Therapies for Severe Asthma in a Diverse Middle Eastern Cohort: Evaluation of Longitudinal Symptom Improvement"],"prefix":"10.7759","author":[{"given":"Mohamed Abdul","family":"Kareem","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shumaila Z","family":"Naqvi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed","family":"Ammar Husain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leon Gerard D","family":"Cruz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed Arshad","family":"Husain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.2147\/TCRM.S160327","article-title":"Unmet needs in asthma","volume":"15","author":"Gruffydd-Jones K","year":"2019","unstructured":"Gruffydd-Jones K. Unmet needs in asthma. Ther Clin Risk Manag. 2019, 15:409-21. 10.2147\/TCRM.S160327","journal-title":"Ther Clin Risk Manag"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201809-1817PP","article-title":"Unmet needs in severe asthma subtyping and precision medicine trials. Bridging clinical and patient perspectives","volume":"199","author":"Siddiqui S","year":"2019","unstructured":"Siddiqui S, Denlinger LC, Fowler SJ, et al.. Unmet needs in severe asthma subtyping and precision medicine trials. Bridging clinical and patient perspectives. Am J Respir Crit Care Med. 2019, 199:823-9. 10.1164\/rccm.201809-1817PP","journal-title":"Am J Respir Crit Care Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0088-2024","article-title":"Biologics in severe asthma: a state-of-the-art review","volume":"34","author":"Gyawali B","year":"2025","unstructured":"Gyawali B, Georas SN, Khurana S. Biologics in severe asthma: a state-of-the-art review. Eur Respir Rev. 2025, 34:10.1183\/16000617.0088-2024","journal-title":"Eur Respir Rev"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2025.1573596","article-title":"The efficacy and safety of biologics for patients with severe asthma: an umbrella review of systematic reviews and meta-analyses","volume":"12","author":"Xiao Q","year":"2025","unstructured":"Xiao Q, Huang Y, Xue B, Wang M. The efficacy and safety of biologics for patients with severe asthma: an umbrella review of systematic reviews and meta-analyses. Front Med. 2025, 12:10.3389\/fmed.2025.1573596","journal-title":"Front Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/ACI.0000000000001081","article-title":"Advancing precision medicine for asthma by focusing on type 2 cytokines and alarmins","volume":"25","author":"Poto R","year":"2025","unstructured":"Poto R, Portacci A, Chan R, Lagnese G, Giovannini M, Varricchi G. Advancing precision medicine for asthma by focusing on type 2 cytokines and alarmins. Curr Opin Allergy Clin Immunol. 2025, 25:269-76. 10.1097\/ACI.0000000000001081","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/cells11172764","article-title":"Current understanding of asthma pathogenesis and biomarkers","volume":"11","author":"Habib N","year":"2022","unstructured":"Habib N, Pasha MA, Tang DD. Current understanding of asthma pathogenesis and biomarkers. Cells. 2022, 11:10.3390\/cells11172764","journal-title":"Cells"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/ACI.0000000000000416","article-title":"Asthma: personalized and precision medicine","volume":"18","author":"Canonica GW","year":"2018","unstructured":"Canonica GW, Ferrando M, Baiardini I, Puggioni F, Racca F, Passalacqua G, Heffler E. Asthma: personalized and precision medicine. Curr Opin Allergy Clin Immunol. 2018, 18:51-8. 10.1097\/ACI.0000000000000416","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14072174","article-title":"Real-world evidence of administration of biologic agents in patients with severe asthma: an analysis of the Respiratory Department of University Hospital of Patras Asthma Registry","volume":"14","author":"Papaioannou O","year":"2025","unstructured":"Papaioannou O, Christopoulos I, Tsiri P, et al.. Real-world evidence of administration of biologic agents in patients with severe asthma: an analysis of the Respiratory Department of University Hospital of Patras Asthma Registry. J Clin Med. 2025, 14:10.3390\/jcm14072174","journal-title":"J Clin Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1080\/02770903.2021.2010749","article-title":"Asthma biologic trial eligibility and real-world outcomes in the United States","volume":"59","author":"Lam RW","year":"2022","unstructured":"Lam RW, Inselman JW, Jeffery MM, Maddux JT, Shah ND, Rank MA. Asthma biologic trial eligibility and real-world outcomes in the United States. J Asthma. 2022, 59:2352-9. 10.1080\/02770903.2021.2010749","journal-title":"J Asthma"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.4103\/atm.ATM_131_20","article-title":"Demographic and clinical patterns of severe asthma in the Middle East","volume":"16","author":"Abuzakouk M","year":"2021","unstructured":"Abuzakouk M, Ghorab OK, Mahboub B, et al.. Demographic and clinical patterns of severe asthma in the Middle East. Ann Thorac Med. 2021, 16:172-7. 10.4103\/atm.ATM_131_20","journal-title":"Ann Thorac Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/462253-real-world-effectiveness-of-biologic-therapies-for-severe-asthma-in-a-diverse-middle-eastern-cohort-evaluation-of-longitudinal-symptom-improvement","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T06:00:47Z","timestamp":1774418447000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/462253-real-world-effectiveness-of-biologic-therapies-for-severe-asthma-in-a-diverse-middle-eastern-cohort-evaluation-of-longitudinal-symptom-improvement"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,24]]},"references-count":10,"URL":"https:\/\/doi.org\/10.7759\/cureus.105804","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,24]]}}}